Feature | Number |
---|---|
n | 35 |
Sex | |
Male | 11 (31%) |
Female | 24 (69%) |
Race | |
Biracial | 1 (2.9%) |
Caucasian | 28 (80%) |
African-American | 6 (17%) |
Age at MRI (years; mean ± SD) | 9.6 ± 4.7 |
Time from diagnosis to MRI (months; mean ± SD) | 2.2 ± 1.8 |
Time from initial symptom to MRI (months; mean ± SD) | 12 ± 17 |
JIA category | |
Oligoarticular | 5 (14%) |
Systemic | 3 (8.6%) |
RF- polyarticular | 14 (40%) |
RF+ polyarticular | 3 (8.6%) |
Psoriatic | 7 (20%) |
Enthesitis-related arthritis | 3 (8.6%) |
Disease activity assessments | |
Swollen joint count | 8.2 ± 8.3 |
ESR (n = 32; mm / hr) | 32 ± 28 |
Physician global assessment (0–10) | 3.3 ± 1.4 |
Exam findings of TMJ activity or damage | |
Maximal incisal opening (n = 34; mm) | 4.5 ± 0.9 |
Jaw deviation (n = 29) | 7 (24%) |
Medications | |
None | 4 (11%) |
Prednisone alone | 2 (5.7%) |
Methotrexate alone | 13 (37%) |
Biologic alone | 3 (8.6%) |
Methotrexate plus biologic | 13 (37%) |